arrow
R

Ribas, Antoni

University of California System
H指数:0
被引数:9

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LANDSCAPE ANALYSIS OF THE NEOEPITOPE-SPECIFIC T CELL RESPONSES IN PATIENTS WITH AND WITHOUT CLINICAL BENEFIT FROM IMMUNE CHECKPOINT BLOCKADE THERAPY
2022-11-070
OA
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
2022-01-2429
OAAI
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma

用cpg-a Toll样受体9激动剂维杜洛莫德克服转移性黑色素瘤患者的PD-1阻滞抗性

2021-07-29101
OAAI
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent CancerTargeted Immune System
2019-02-018
OAAI
Gene Expression Profiling in BRAF-Mutated Melanoma Reveals Patient Subgroups with Poor Outcomes to Vemurafenib That May Be Overcome by Cobimetinib Plus Vemurafenib
2017-08-3125
OAAI
Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
2014-04-30214
OAAI